High-risk tracheostomy

Exploring the limits of the percutaneous tracheostomy

D. Russ Blankenship, Brian D. Kulbersh, Christine G. Gourin, Amy Renee Blanchard, David J Terris

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Objectives: Modifications of the percutaneous tracheostomy (PercTrach) technique have made this a straightforward and safe procedure in appropriately selected patients. We sought to determine its value in high-risk patients. Study Design/Methods: A retrospective study of high-risk and low-risk patients on whom bedside PercTrach was performed between May 2003 and October 2004 at the Medical College of Georgia. The patients were prospectively stratified into groups based on their comorbidities (morbid obesity or coagulopathy). The Ciaglia Blue Rhino introducer set was used in all cases. Results: Fifty-four consecutive patients were included in the study; the high-risk patients (n = 16) were younger than the low-risk (n = 38) patients (48.2 vs. 53.6 years, respectively), but had significantly higher Acute Physiology and Chronic Health Evaluation II scores (10.1 vs. 5.4, P = .0001). There were seven morbidly obese patients with a mean body mass index of 64.4 and a mean weight of 184.9 kg. There were 9 patients with a total of 10 coagulopathic conditions (7 = International Normalized Ratio [INR] of > 1.5, 2 = heparin drip, 1 = platelet count < 20,000). One patient included in the study met requirements for two categories with a platelet count of 17,000 and an INR of 1.7. The procedural times ranged from 5 to 30 minutes. The high-risk PercTrachs took 14.4 ± 5.0 minutes on average, compared with 12.2 ± 4.8 minutes in the low-risk group (P = .115). One patient in the low-risk group bled from an anterior jugular communicating vein injury, requiring wound exploration and vein ligation. There were no other significant complications. Conclusions: There were no statistically significant differences in intraoperative or perioperative outcomes between the PercTrachs performed in high-risk versus low-risk patients. PercTrachs may be performed safely even in high-risk patients such as those with morbid obesity and coagulopathy.

Original languageEnglish (US)
Pages (from-to)987-989
Number of pages3
JournalLaryngoscope
Volume115
Issue number6
DOIs
StatePublished - Jun 1 2005

Fingerprint

Tracheostomy
International Normalized Ratio
Morbid Obesity
Platelet Count
APACHE
Jugular Veins
Ligation
Heparin
Comorbidity
Veins
Body Mass Index
Retrospective Studies

Keywords

  • Bronchoscopic
  • High-risk
  • Morbid obesity
  • Percutaneous
  • Tracheostomy

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

High-risk tracheostomy : Exploring the limits of the percutaneous tracheostomy. / Blankenship, D. Russ; Kulbersh, Brian D.; Gourin, Christine G.; Blanchard, Amy Renee; Terris, David J.

In: Laryngoscope, Vol. 115, No. 6, 01.06.2005, p. 987-989.

Research output: Contribution to journalArticle

Blankenship, D. Russ ; Kulbersh, Brian D. ; Gourin, Christine G. ; Blanchard, Amy Renee ; Terris, David J. / High-risk tracheostomy : Exploring the limits of the percutaneous tracheostomy. In: Laryngoscope. 2005 ; Vol. 115, No. 6. pp. 987-989.
@article{2cb29fef53e14ae197a73e747218dd61,
title = "High-risk tracheostomy: Exploring the limits of the percutaneous tracheostomy",
abstract = "Objectives: Modifications of the percutaneous tracheostomy (PercTrach) technique have made this a straightforward and safe procedure in appropriately selected patients. We sought to determine its value in high-risk patients. Study Design/Methods: A retrospective study of high-risk and low-risk patients on whom bedside PercTrach was performed between May 2003 and October 2004 at the Medical College of Georgia. The patients were prospectively stratified into groups based on their comorbidities (morbid obesity or coagulopathy). The Ciaglia Blue Rhino introducer set was used in all cases. Results: Fifty-four consecutive patients were included in the study; the high-risk patients (n = 16) were younger than the low-risk (n = 38) patients (48.2 vs. 53.6 years, respectively), but had significantly higher Acute Physiology and Chronic Health Evaluation II scores (10.1 vs. 5.4, P = .0001). There were seven morbidly obese patients with a mean body mass index of 64.4 and a mean weight of 184.9 kg. There were 9 patients with a total of 10 coagulopathic conditions (7 = International Normalized Ratio [INR] of > 1.5, 2 = heparin drip, 1 = platelet count < 20,000). One patient included in the study met requirements for two categories with a platelet count of 17,000 and an INR of 1.7. The procedural times ranged from 5 to 30 minutes. The high-risk PercTrachs took 14.4 ± 5.0 minutes on average, compared with 12.2 ± 4.8 minutes in the low-risk group (P = .115). One patient in the low-risk group bled from an anterior jugular communicating vein injury, requiring wound exploration and vein ligation. There were no other significant complications. Conclusions: There were no statistically significant differences in intraoperative or perioperative outcomes between the PercTrachs performed in high-risk versus low-risk patients. PercTrachs may be performed safely even in high-risk patients such as those with morbid obesity and coagulopathy.",
keywords = "Bronchoscopic, High-risk, Morbid obesity, Percutaneous, Tracheostomy",
author = "Blankenship, {D. Russ} and Kulbersh, {Brian D.} and Gourin, {Christine G.} and Blanchard, {Amy Renee} and Terris, {David J}",
year = "2005",
month = "6",
day = "1",
doi = "10.1097/01.MLG.0000163107.80668.12",
language = "English (US)",
volume = "115",
pages = "987--989",
journal = "Laryngoscope",
issn = "0023-852X",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - High-risk tracheostomy

T2 - Exploring the limits of the percutaneous tracheostomy

AU - Blankenship, D. Russ

AU - Kulbersh, Brian D.

AU - Gourin, Christine G.

AU - Blanchard, Amy Renee

AU - Terris, David J

PY - 2005/6/1

Y1 - 2005/6/1

N2 - Objectives: Modifications of the percutaneous tracheostomy (PercTrach) technique have made this a straightforward and safe procedure in appropriately selected patients. We sought to determine its value in high-risk patients. Study Design/Methods: A retrospective study of high-risk and low-risk patients on whom bedside PercTrach was performed between May 2003 and October 2004 at the Medical College of Georgia. The patients were prospectively stratified into groups based on their comorbidities (morbid obesity or coagulopathy). The Ciaglia Blue Rhino introducer set was used in all cases. Results: Fifty-four consecutive patients were included in the study; the high-risk patients (n = 16) were younger than the low-risk (n = 38) patients (48.2 vs. 53.6 years, respectively), but had significantly higher Acute Physiology and Chronic Health Evaluation II scores (10.1 vs. 5.4, P = .0001). There were seven morbidly obese patients with a mean body mass index of 64.4 and a mean weight of 184.9 kg. There were 9 patients with a total of 10 coagulopathic conditions (7 = International Normalized Ratio [INR] of > 1.5, 2 = heparin drip, 1 = platelet count < 20,000). One patient included in the study met requirements for two categories with a platelet count of 17,000 and an INR of 1.7. The procedural times ranged from 5 to 30 minutes. The high-risk PercTrachs took 14.4 ± 5.0 minutes on average, compared with 12.2 ± 4.8 minutes in the low-risk group (P = .115). One patient in the low-risk group bled from an anterior jugular communicating vein injury, requiring wound exploration and vein ligation. There were no other significant complications. Conclusions: There were no statistically significant differences in intraoperative or perioperative outcomes between the PercTrachs performed in high-risk versus low-risk patients. PercTrachs may be performed safely even in high-risk patients such as those with morbid obesity and coagulopathy.

AB - Objectives: Modifications of the percutaneous tracheostomy (PercTrach) technique have made this a straightforward and safe procedure in appropriately selected patients. We sought to determine its value in high-risk patients. Study Design/Methods: A retrospective study of high-risk and low-risk patients on whom bedside PercTrach was performed between May 2003 and October 2004 at the Medical College of Georgia. The patients were prospectively stratified into groups based on their comorbidities (morbid obesity or coagulopathy). The Ciaglia Blue Rhino introducer set was used in all cases. Results: Fifty-four consecutive patients were included in the study; the high-risk patients (n = 16) were younger than the low-risk (n = 38) patients (48.2 vs. 53.6 years, respectively), but had significantly higher Acute Physiology and Chronic Health Evaluation II scores (10.1 vs. 5.4, P = .0001). There were seven morbidly obese patients with a mean body mass index of 64.4 and a mean weight of 184.9 kg. There were 9 patients with a total of 10 coagulopathic conditions (7 = International Normalized Ratio [INR] of > 1.5, 2 = heparin drip, 1 = platelet count < 20,000). One patient included in the study met requirements for two categories with a platelet count of 17,000 and an INR of 1.7. The procedural times ranged from 5 to 30 minutes. The high-risk PercTrachs took 14.4 ± 5.0 minutes on average, compared with 12.2 ± 4.8 minutes in the low-risk group (P = .115). One patient in the low-risk group bled from an anterior jugular communicating vein injury, requiring wound exploration and vein ligation. There were no other significant complications. Conclusions: There were no statistically significant differences in intraoperative or perioperative outcomes between the PercTrachs performed in high-risk versus low-risk patients. PercTrachs may be performed safely even in high-risk patients such as those with morbid obesity and coagulopathy.

KW - Bronchoscopic

KW - High-risk

KW - Morbid obesity

KW - Percutaneous

KW - Tracheostomy

UR - http://www.scopus.com/inward/record.url?scp=20144376023&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20144376023&partnerID=8YFLogxK

U2 - 10.1097/01.MLG.0000163107.80668.12

DO - 10.1097/01.MLG.0000163107.80668.12

M3 - Article

VL - 115

SP - 987

EP - 989

JO - Laryngoscope

JF - Laryngoscope

SN - 0023-852X

IS - 6

ER -